Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012;19(2):121-30.
doi: 10.1159/000330247. Epub 2012 Jan 11.

Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier

Michelle A Erickson  1 , Kenji Dohi, William A Banks
Affiliations
Review

Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier

Michelle A Erickson et al. Neuroimmunomodulation. 2012.

Abstract

The blood-brain barrier (BBB) is not simply a physical barrier but a regulatory interface between the central nervous system (CNS) and immune system. The BBB both affects and is affected by the immune system and connects at many levels with the CNS, including the following: (1) the BBB transports cytokines and secretes various substances with neuroinflammatory properties; (2) transporters are altered in disease states including traumatic injury, Alzheimer's disease and inflammatory processes; (3) cytokines and other immune secretions from the cells comprising the BBB are both constitutive and inducible; (4) immune cells are transported across the BBB by the highly regulated process termed diapedesis, which involves communication and interactions between the brain endothelial cells and the immune cells; (5) the neuroimmune system has various effects on the BBB, including modulation of important transport systems and in extreme pathological conditions even disruption of the BBB, and (6) the brain-to-blood efflux transporter P-glycoprotein is altered in inflammatory conditions, thus affecting drug delivery to the brain. In summary, the BBB is an interactive interface that regulates and defines many of the ways that the CNS and the immune system communicate with one another.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
An endocentric view of neuroinflammation. (1) Disruption of BBB integrity and disassembly of tight junctions permits transcellular (la) and paracellular (lb) entry of circulating components. (2) Circulating cytokines are transported across the BBB into the brain. (3) BBB endothelial cells are activated by circulating cytokines and other circulating inflammatory mediators, causing secretion of inflammatory mediators including cytokines into the brain parenchyma (3a) and alterations in the transport of substances across the BBB (3b). (4) Circulating immune cells cross the BBB via diapedesis by paracellular (4a) and transcellular (4b) pathways. (5) Circulating cytokines bypass the BBB by inflammatory activation of vagai afférents (5a) or inflammatory mediators crossing the leaky vasculature into circumventricular organs (CVOs; 5b), which are compartmentalized from the rest of the CNS by tanycytic barriers. PNS = Peripheral nervous system.
Fig. 2
Fig. 2
Inflammatory regulation of LRP-1. Aß is transported across the BBB in the brain-to-blood direction (efflux) by the transporter LRP-1. In AD, LRP-1 is down-regulated at the BBB and decreased efflux of Aß occurs, contributing to Aß accumulation in the CNS. Inflammation induced by peripheral administration of LPS reduces Aß efflux via LRP-1, and this is inhibited by indomethacin. Diabetes causes downregulation of LRP-1 at the BBB. Both LPS and diabetes cause inflammation and oxidative stress in the CNS, which could potentially contribute to LRP-1 dysfunction.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Goehler LE, Gaykema RP, Nguyen KT, Lee JE, Tilders FJ, Maier SF, Watkins LR. Interleukin-1 beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems? J Neurosci. 1999;19:2799–2806. - PMC - PubMed
    1. Watkins LR, Maier SF, Goehler LE. Cytokine-to-brain communication: a review & analysis of alternative mechanisms. Life Sci. 1995;57:1011–1026. - PubMed
    1. Avison MJ, Nath A, Greene-Avison R, Schmitt FA, Bales RA, Ethisham A, Greenberg RN, Berger JR. Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia. J Neurovirol. 2004;10:223–232. - PubMed
    1. Chou S, Dix RD. Viral infections and the blood-brain barrier. In: Neuwelt EA, editor. Implications of the Blood-Brain Barrier and Its Manipulation, vol 2: Clinical Aspects. New York: Plenum; 1989. pp. 449–468.
    1. Rapoport SI. Pathological Alterations of the Blood-Brain Barrier; Blood-Brain Barrier in Physiology and Medicine. New York: Raven; 1976. pp. 129–152.

Publication types

MeSH terms